Home / Drug shortages / Lidocaine Hydrochloride Injection

Lidocaine Hydrochloride Injection — FDA Drug Shortage

Current — Amphastar Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Lidocaine Hydrochloride Injection (injection) from Amphastar Pharmaceuticals, Inc. with status Current. The shortage was first posted on 02/22/2012. Reported reason: Demand increase for the drug

Shortage Details

Status
Current
Company
Amphastar Pharmaceuticals, Inc.
Package NDC
76329-3390-1
Dosage Form
Injection
Presentation
Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1)
Initial Posting
02/22/2012
Revised Date

Reason

Demand increase for the drug

FDA data resources